Rina Kennedy

Statistics

Publications

Citations

H-Index

Active since

2013

Affiliations

Rina Kennedy is an author at Morphotek (United States) specializing in antibody-dependent cell-mediated cytotoxicity, monoclonal antibodies in oncology, and antibody-dependent cellular cytotoxicity.

Publications per year

2013–2017

Publications

The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity

Jianmin Lin, Jared Spidel, Christopher Maddage et al. · Cancer Biology & Therapy · 2013 · 54 citations · Full text

Medicine, Oncology, Pharmacology +16

Tumor antigen CA125 suppresses antibody-dependent cellular cytotoxicity (ADCC) via direct antibody binding and suppressed Fc-γ receptor engagement

J. Bradford Kline, Rina Kennedy, Earl F. Albone et al. · Oncotarget · 2017 · 32 citations · Full text

Life Sciences, Immunology, Oncology +15

1–2 of 2